A citation-based method for searching scientific literature

Katharina Schlacher, Nicole Christ, Nicolas Siaud, Akinori Egashira, Hong Wu, Maria Jasin. Cell 2011
Times Cited: 745



Nicholas J Panzarino, John J Krais, Ke Cong, Min Peng, Michelle Mosqueda, Sumeet U Nayak, Samuel M Bond, Jennifer A Calvo, Mihir B Doshi, Matt Bere, Jianhong Ou, Bin Deng, Lihua J Zhu, Neil Johnson, Sharon B Cantor. Cancer Res 2021
Times Cited: 31




List of shared articles



Times cited

PRIMPOL ready, set, reprime!
Stephanie Tirman, Emily Cybulla, Annabel Quinet, Alice Meroni, Alessandro Vindigni. Crit Rev Biochem Mol Biol 2021
4

Targeting translesion synthesis (TLS) to expose replication gaps, a unique cancer vulnerability.
Sumeet Nayak, Jennifer A Calvo, Sharon B Cantor. Expert Opin Ther Targets 2021
5

The phospho-dependent role of BRCA2 on the maintenance of chromosome integrity.
Åsa Ehlén, Gaetana Sessa, Sophie Zinn-Justin, Aura Carreira. Cell Cycle 2021
2

Repriming DNA synthesis: an intrinsic restart pathway that maintains efficient genome replication.
Lewis J Bainbridge, Rebecca Teague, Aidan J Doherty. Nucleic Acids Res 2021
4

Shaping the BRCAness mutational landscape by alternative double-strand break repair, replication stress and mitotic aberrancies.
Colin Stok, Yannick P Kok, Nathalie van den Tempel, Marcel A T M van Vugt. Nucleic Acids Res 2021
7


Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer.
Vijayalaxmi G Gupta, Jeff Hirst, Shariska Petersen, Katherine F Roby, Meghan Kusch, Helen Zhou, Makena L Clive, Andrea Jewell, Harsh B Pathak, Andrew K Godwin,[...]. Gynecol Oncol 2021
3


Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Ke Cong, Min Peng, Arne Nedergaard Kousholt, Wei Ting C Lee, Silviana Lee, Sumeet Nayak, John Krais, Pamela S VanderVere-Carozza, Katherine S Pawelczak, Jennifer Calvo,[...]. Mol Cell 2021
24

REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.
Angelo Taglialatela, Giuseppe Leuzzi, Vincenzo Sannino, Raquel Cuella-Martin, Jen-Wei Huang, Foon Wu-Baer, Richard Baer, Vincenzo Costanzo, Alberto Ciccia. Mol Cell 2021
9

Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps.
Mariana Paes Dias, Vivek Tripathi, Ingrid van der Heijden, Ke Cong, Eleni-Maria Manolika, Jinhyuk Bhin, Ewa Gogola, Panagiotis Galanos, Stefano Annunziato, Cor Lieftink,[...]. Mol Cell 2021
5